Locally Optimised Contouring With AI Technology for Radiotherapy
LOCATOR - Locally Optimised Contouring With AI Technology for Radiotherapy
Royal North Shore Hospital
444 participants
Feb 11, 2025
INTERVENTIONAL
Conditions
Summary
LOCATOR is a multicentre phase II randomised clinical trial that is looking at the process of contouring in radiation treatment for breast cancer patients. This study looks at whether contouring aided by artificial intelligence (AI) is comparable in quality to that of contouring done completely manually by a radiation oncologist. We are also looking at whether AI assisted contouring saves radiation oncologists time when compared to fully manual contouring. LOCATOR uses the LOCATOR software which is an in-house software developed locally and trained on local data.
Eligibility
Inclusion Criteria4
- years and older who are planned for primary breast malignancy
- ECOG performance 0-2
- Ability to understand and willingness to sign a written informed consent document
- The target volume must be able to be objectively reviewed by current published national or international clinical guidelines
Exclusion Criteria2
- Patients under 18 years of age
- Patients unable to understand consent documents
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Initial are generated automatically using software powered by artificial intelligence
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06546592